Goldman Sachs’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-72,700
| Closed | -$5.5M | – | 6770 |
|
|
2026
Q1 | $5.5M | Buy |
+72,700
| New | +$5.47M | ﹤0.01% | 3604 |
|
|
2018
Q1 | – | Sell |
-13,300
| Closed | -$569K | – | 6095 |
|
|
2017
Q4 | $569K | Sell |
13,300
-500
| -4% | -$19.9K | ﹤0.01% | 4727 |
|
|
2017
Q3 | $506K | Buy |
13,800
+8,000
| +138% | +$323K | ﹤0.01% | 5076 |
|
|
2017
Q2 | $263K | Sell |
5,800
-1,400
| -19% | -$61.8K | ﹤0.01% | 5604 |
|
|
2017
Q1 | $306K | Sell |
7,200
-11,800
| -62% | -$481K | ﹤0.01% | 5447 |
|
|
2016
Q4 | $762K | Buy |
19,000
+10,500
| +124% | +$405K | ﹤0.01% | 4692 |
|
|
2016
Q3 | $330K | Buy |
8,500
+1,400
| +20% | +$52.9K | ﹤0.01% | 5402 |
|
|
2016
Q2 | $246K | Buy |
7,100
+400
| +6% | +$13.9K | ﹤0.01% | 5518 |
|
|
2016
Q1 | $231K | Sell |
6,700
-67,000
| -91% | -$2.34M | ﹤0.01% | 5492 |
|
|
2015
Q4 | $2.85M | Sell |
73,700
-108,800
| -60% | -$4.23M | ﹤0.01% | 3321 |
|
|
2015
Q3 | $7.14M | Buy |
182,500
+151,700
| +493% | +$6.02M | ﹤0.01% | 2556 |
|
|
2015
Q2 | $1.17M | Buy |
30,800
+15,100
| +96% | +$529K | ﹤0.01% | 4395 |
|
|
2015
Q1 | $518K | Buy |
15,700
+10,400
| +196% | +$319K | ﹤0.01% | 5090 |
|
|
2014
Q4 | $142K | Sell |
5,300
-1,000
| -16% | -$25.8K | ﹤0.01% | 6395 |
|
|
2014
Q3 | $153K | Sell |
6,300
-1,100
| -15% | -$27.8K | ﹤0.01% | 6359 |
|
|
2014
Q2 | $188K | Sell |
7,400
-50,600
| -87% | -$1.18M | ﹤0.01% | 6243 |
|
|
2014
Q1 | $1.25M | Sell |
58,000
-162,100
| -74% | -$3.5M | ﹤0.01% | 4450 |
|
|
2013
Q4 | $4.92M | Sell |
220,100
-478,900
| -69% | -$10.6M | ﹤0.01% | 3097 |
|
|
2013
Q3 | $14.4M | Buy |
699,000
+160,200
| +30% | +$3.41M | 0.01% | 1892 |
|
|
2013
Q2 | $10.4M | Buy |
+538,800
| New | +$11.3M | ﹤0.01% | 2050 |
|
Other funds holding HOLX
Goldman Sachs's HOLX Position: Q2 2026 in Review
Goldman Sachs sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,322,673 shares — an estimated $176M sold.
Goldman Sachs first reported a position in HOLX in Q2 2013 and held it in 52 quarters. The position peaked at $253M in Q1 2021. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Goldman Sachs reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Goldman Sachs sold 2,322,673 Hologic shares in Q2 2026, an estimated $176M.
- Goldman Sachs first reported a position in Hologic in Q2 2013 and held it in 52 quarters.
- Goldman Sachs's Hologic position peaked at $253M in Q1 2021.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.